Send to

Choose Destination
JCI Insight. 2018 Feb 22;3(4). pii: 97440. doi: 10.1172/jci.insight.97440. [Epub ahead of print]

CHD7 represses the retinoic acid synthesis enzyme ALDH1A3 during inner ear development.

Author information

Department of Pediatrics and Communicable Diseases.
College of Literature, Science, and the Arts.
Department of Human Genetics.
Medical Scientist Training Program, and.
Department of Otolaryngology, University of Michigan, Ann Arbor, Michigan, USA.
Department of Genetics, Case Western Reserve University, Cleveland, Ohio, USA.


CHD7, an ATP-dependent chromatin remodeler, is disrupted in CHARGE syndrome, an autosomal dominant disorder characterized by variably penetrant abnormalities in craniofacial, cardiac, and nervous system tissues. The inner ear is uniquely sensitive to CHD7 levels and is the most commonly affected organ in individuals with CHARGE. Interestingly, upregulation or downregulation of retinoic acid (RA) signaling during embryogenesis also leads to developmental defects similar to those in CHARGE syndrome, suggesting that CHD7 and RA may have common target genes or signaling pathways. Here, we tested three separate potential mechanisms for CHD7 and RA interaction: (a) direct binding of CHD7 with RA receptors, (b) regulation of CHD7 levels by RA, and (c) CHD7 binding and regulation of RA-related genes. We show that CHD7 directly regulates expression of Aldh1a3, the gene encoding the RA synthetic enzyme ALDH1A3 and that loss of Aldh1a3 partially rescues Chd7 mutant mouse inner ear defects. Together, these studies indicate that ALDH1A3 acts with CHD7 in a common genetic pathway to regulate inner ear development, providing insights into how CHD7 and RA regulate gene expression and morphogenesis in the developing embryo.


Development; Embryonic development; Genetic diseases; Neuroscience

Supplemental Content

Full text links

Icon for American Society for Clinical Investigation Icon for PubMed Central
Loading ...
Support Center